Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jasper Therapeutics

5.15
-0.1100-2.09%
Post-market: 5.03-0.1200-2.33%17:46 EDT
Volume:185.75K
Turnover:957.18K
Market Cap:77.36M
PE:-0.98
High:5.48
Open:5.30
Low:5.01
Close:5.26
Loading ...
Jul 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 19, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 19, 2021

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Jul 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 21, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 14, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 09, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 08, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 01, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 26, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 24, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
May 24, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 19, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 18, 2021

Major Issues Report

8-K - Current report
May 07, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 07, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 06, 2021

Major Issues Report

8-K - Current report
Mar 30, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]